Endometrial carcinoma in tamoxifen-treated breast cancer patients.

  title={Endometrial carcinoma in tamoxifen-treated breast cancer patients.},
  author={Giovanna Spinelli and N Bardazzi and A C Citernesi and M C Fontanarosa and Pietro Curiel},
  journal={Journal of chemotherapy},
  volume={3 4},
Tamoxifen is an important agent for the treatment of breast cancer. Occasionally the drug, which is an antiestrogen, has agonistic estrogenic activity. The authors describe three new cases of endometrial carcinoma developing in breast cancer patients taking tamoxifen and stress the necessity of carefully monitoring the uterine cavity under tamoxifen treatment. 

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…